GB Sciences Inc | PotStockNews

GB Sciences Launches Global Expansion in Canada with GBS Global Biopharma, Inc.

Expedites innovative cannabinoid medicine program, covering 60 disease and health conditions including Parkinson's Disease, neuropathic pain and cardiac hypertrophy LAS VEGAS, March 19, 2019 /CNW/ -- GB Sciences, Inc. (OTCQB:GBLX) today launched a global expansion strategy with the formation ... [Read]

GB Sciences Completes Harvest of First Cannabis Crop in Partnership with The Louisiana State University Agricultural Research Center

Jan 16

Nationally recognized collaboration with the Louisiana State University Agricultural Center LAS VEGAS, Jan. 16, 2019 /CNW/ -- GB Sciences, Inc. (OTCQB:GBLX) announced the harvest of the first test cannabis crop in the company's nationally-recognized collaboration with Louisiana State University Agricultural Center. On November ... [Read]

GB Sciences Declares A “Research Revolution” At Its “2018 Innovation In Medical Cannabis Therapies” Symposium

Dec 14

On November 9th, GB Sciences hosted an open mic-dialogue with key stakeholders in the cannabis industry that focused on addressing medical patients' needs through improved standardization and innovation of future medical cannabis products. LAS VEGAS, Dec. 14, ... [Read]

GB Sciences and The Colorado Hemp Project Sell First Hemp Crop for $0.7 Million Dollars

Dec 12

LAS VEGAS, Dec. 12, 2018 /CNW/ -- GB Sciences, Inc. (OTCQB:GBLX) announces that their first crop in the rapidly expanding hemp market expects to yield a gross profit of $0.7million dollars as well as seeds and genetics. These seeds ... [Read]

Dr. Andrea Small-Howard, GB Sciences’ Chief Science Officer, Introduces, “Unique Methods to Identify Strong Lead Compounds” at the International Cannabinoid Derived Pharmaceutical Summit

Dec 11

LAS VEGAS, Dec. 11, 2018 /CNW/ -- GB Sciences, Inc. (OTCQB:GBLX) announced today that Dr. Andrea Small-Howard, Chief Science Officer and GB Sciences' Board Member, will present "Unique Methods to Identify Strong Lead Compounds" at the International Cannabinoid-Derived Pharmaceuticals ... [Read]

GB Sciences and Louisiana State University Agricultural Center Enter a Joint Research and Development Agreement for the Production of Therapeutic Cannabis Targeting Severe Medical Conditions and Diseases

Dec 7

As a Public Institution of Higher Education, the LSU AgCenter's public/private partnership with GB Sciences represents a first in the therapeutic cannabis industry LAS VEGAS, Dec. 7, 2018 /CNW/ -- GB Sciences, Inc. (OTCQB:GBLX) announces on November 19, ... [Read]

GB Sciences Co-Authors a Peer-Reviewed Article Showing that Heart Failure Can Be Mitigated, and Reversed, by Orally Administered Drugs Targeting a Cellular Cannabinoid Receptor

Nov 27

Syndicated under license via QuoteMedia Pioneering new scientific research in the publication, Channels, explains the promise of targeting the ionotropic cannabinoid receptor TRPV1, for the treatment and reversal of heart failure. LAS VEGAS, Nov. 27, 2018 /CNW/ ... [Read]

GB Sciences Files First Of Its Kind Provisional Patent Application For The Treatment Of Neuropathic Pain Using Time-Released, Myrcene-Based Nanoparticles

Nov 20

Syndicated under license via QuoteMedia First of their kind, myrcene nanoparticles are central to a novel, time-released therapeutic for neuropathic pain LAS VEGAS, Nov. 20, 2018 /CNW/ -- GB Sciences, Inc. (OTCQB:GBLX) and the Universidad de Sevilla (USE) announce the ... [Read]

GB Sciences Expands into the Oklahoma Medical Cannabis Market

Nov 14

Syndicated under license via QuoteMedia GB Sciences' signs a letter of binding agreement with 4EVERGRN in its first out-of-state licensing deal. LAS VEGAS, Nov. 14, 2018 /CNW/ -- GB Sciences, Inc. (OTCQB:GBLX) is proud to announce that it ... [Read]